Cosmo Pharmaceuticals N.V.
OTC: CMOPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Giovanni di Napoli
- Employees
- 324
- Headquarters
- Dublin, Ireland
- IPO year
- 2017
- Market cap
- $1.4B
- Website
- https://www.cosmopharma.com
Loading CMOPF…
Loading profile data…Frequently asked questions about CMOPF
What does Cosmo Pharmaceuticals N.V. (CMOPF) do?
Cosmo Pharmaceuticals N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescripti...
Where does CMOPF trade?
Cosmo Pharmaceuticals N.V. (CMOPF) trades on the Other OTC.
What sector is CMOPF in?
Cosmo Pharmaceuticals N.V. (CMOPF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Cosmo Pharmaceuticals N.V.?
Giovanni di Napoli is the chief executive officer of Cosmo Pharmaceuticals N.V. (CMOPF).
Where is Cosmo Pharmaceuticals N.V. headquartered?
Cosmo Pharmaceuticals N.V. is headquartered in Ireland.
Does CMOPF pay a dividend?
Yes — Cosmo Pharmaceuticals N.V. (CMOPF) paid a trailing twelve-month dividend of USD 2.46 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CMOPF go public?
Cosmo Pharmaceuticals N.V. (CMOPF) completed its initial public offering in 2017.